|Mr. Zhi Qiang Lu||Chief Exec. Officer, Compliance Officer and Exec. Director||519k||N/A||42|
|Dr. Kao Kun Lin||Vice Chairman||504k||N/A||67|
|Mr. Kwong Kau Chui||Exec. Director||658k||N/A||50|
|Ms. Mei Li||Exec. Director||179k||N/A||37|
|Mr. Hongqing Jiang||Exec. Director||504k||N/A||49|
Hong Kong Life Sciences and Technologies Group Limited, an investment holding company, operates in the anti-aging and stem cell technology, trading, and money lending businesses in the Peoples Republic of China and Hong Kong. It offers stem cell storage and processing, anti-aging and beauty, and stem cell technology related services. The company also distributes biomedical and life sciences products; provides secured and unsecured loans for individuals and corporations, as well as trades and invests in securities. In addition, it trades in electronic components and metals. The company was formerly known as ZMAY Holdings Limited and changed its name to Hong Kong Life Sciences and Technologies Group Limited in October 2012. Hong Kong Life Sciences and Technologies Group Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.
Hong Kong Life Sciences and Technologies Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.